Each tablet contains Nebivolol 2.5 mg or 5 mg.

Nebilong Tablets contain Nebivolol, a highly selective beta1-adrenergic receptor blocker with vasodilatory properties indicated for the management of hypertension. Nebivolol lowers blood pressure by reducing heart rate, myocardial contractility, sympathetic nervous system activity, and peripheral vascular resistance while preserving cardiac function. Its once-daily dosing regimen provides sustained 24-hour blood pressure control and improves patient adherence to long-term antihypertensive therapy.

Nebilong Tablets are indicated for the treatment of essential hypertension in adult patients.

Nebivolol is a highly selective β1-adrenergic receptor blocker that exerts its antihypertensive effect through several complementary mechanisms. It decreases heart rate and myocardial contractility, suppresses renin release from the kidneys, reduces sympathetic nervous system activity originating from cerebral vasomotor centers, promotes vasodilation, and decreases peripheral vascular resistance. These combined actions effectively lower arterial blood pressure while maintaining favorable cardiovascular hemodynamics.

The recommended dosage is one tablet once daily, with or without food. The dose should be individualized according to the patient's clinical response and blood pressure control under the supervision of a healthcare professional.

Nebilong Tablets are contraindicated in patients with known hypersensitivity to Nebivolol or any component of the formulation, heart block greater than first degree, cardiogenic shock, decompensated cardiac failure, and sick sinus syndrome, unless a permanent pacemaker is in place.